Shenzhen Capital Group Co., Ltd (SCGC) is a venture capital firm founded in 1999 by the Shenzhen Government. The company is dedicated to fostering national industries, developing national brands, and promoting economic transformation through investments in emerging sectors. SCGC primarily targets small to medium enterprises and innovative high-tech companies, focusing on those in various stages of growth, including startups and those undergoing transformation. Its investment portfolio spans industries that align with national policy support, such as information technology, internet services, new media, biopharmaceuticals, new energy, environmental protection, chemical engineering, and high-end equipment manufacturing. With a registered capital of 5.42 billion RMB and significant assets under management, SCGC has established itself as a leader in the venture capital landscape, having invested in numerous companies, many of which have achieved public listings across global capital markets.
Fl.11, Investment Building, No.4009 Shennan Road, Futian Center District, Shenzhen 518048, China
Fang Aihua
Investment Director
Haitao Jin
Chairman
Suhua Liu
President
Zhou Songgan
Investment Manager
Xidong Wang
Vice President
Lin Yunyu
Investment Director
Ding Zuo
Chairman
Past deals in Asia
Supreium Technology
Series B in 2024
Supreium specializes in the development of computer-aided engineering (CAE) simulation software solutions tailored for intelligent manufacturing. Founded in 2016 and headquartered in Beijing, China, the company offers a software as a service (SaaS) platform that includes various services such as mold design, injection process analysis, and thermal balance assessments. Its offerings also encompass automatic defect detection through image scanning and process consulting services. Serving diverse sectors including medical treatment, marine water conservancy, communications, and industrial markets, Supreium is committed to advancing high-performance digital solutions through its innovative algorithms and cloud-native simulation technologies. The company is recognized for its focus on intelligent industrial design applications and is positioned at the forefront of CAE technology development.
Xvisio Technology
Series B in 2024
Xvisio Technology is a Shanghai-based company that specializes in designing and developing virtual reality and augmented reality products. The firm focuses on visual simultaneous localization and mapping (VSLAM) technologies, providing solutions for spatial perception and interaction in various applications. Its product offerings include the SeerSense sensor hub, which features low latency 6DOF tracking, depth sensing, and AI capabilities for robotics and automated guided vehicle navigation, as well as the SeerLens AR glasses, which are lightweight and equipped with built-in 6DOF tracking. Xvisio Technology serves a range of industries, including robotics, drones, logistics, gaming, manufacturing, and automotive, and has an additional office in Milpitas, California. The company's innovations enable advanced mapping, 3D environmental reconstruction, and object recognition, positioning it as a key player in the XR technology landscape.
Hangxing Transmission
Series A in 2024
Beijing Hangxing Transmission Technology is a development and batch production of various servo systems in the fields of aerospace, aviation and navigation. They have rich experience in industry development and mass production and have more than 40 R&D and design personnel, craftsmen, and skilled personnel.
Bio-Link
Venture Round in 2024
Bio-Link is a drug development company established in 2001 and headquartered in Shanghai, China. It specializes in providing bioprocessing solutions for the life science industry, focusing on the development and manufacturing of essential process equipment and consumables. These products are utilized in the production of vaccines, antibody drugs, cell therapy, gene therapy, and other biologics. Bio-Link's offerings encompass upstream cell culture, disposable dispensing reservoirs, downstream chromatography, ultrafiltration, and filtration, along with process development services. The company aims to deliver high-quality and innovative solutions that enhance the efficiency, safety, and competitiveness of the biopharmaceutical supply chain. Additionally, there are indications that Bio-Link may explore wearable technology aimed at elderly care.
Mingdu Zhiyun
Series C in 2024
Mingdu Zhiyun, established in 2017 and located in Hangzhou, China, offers comprehensive contract manufacturing services for pharmaceutical companies. The company specializes in full life cycle solutions that encompass research and development, production, warehousing, and logistics. By leveraging advanced information management systems powered by big data and artificial intelligence, Mingdu Zhiyun enhances the efficiency of the R&D process, enabling drug manufacturers to streamline the development, production, and registration of pharmaceutical products.
Edrive Space
Series B in 2024
Edrive Space specializes in developing advanced aerospace propulsion systems aimed at enhancing the aerospace industry, particularly in China. The company focuses on electrothermal micro-propulsion technologies that address the limitations of traditional electric propulsion systems, such as excessive weight, high power requirements, and low thrust. Their products are designed for the efficient orbiting and networking of micro-nano satellites, making them suitable for applications like emergency collision avoidance of space debris and active deorbiting. Edrive Space's solutions cater to the growing demand for low-cost, standardized, and scalable propulsion systems in the commercial satellite sector, positioning the company as a key player in the evolving landscape of satellite technology.
Unitree Robotics
Series B in 2024
Unitree Robotics, founded in 2016 and based in Hangzhou, China, specializes in the development of innovative robotic solutions for consumer and industrial markets. The company's diverse portfolio features a range of robots, including quadrupeds like Laikago, a four-legged robodog designed as a research platform for scientists and roboticists. Additionally, Unitree Robotics offers humanoid robots and advanced perception systems, catering to various applications across different sectors.
Homerun Smart
Series C in 2023
Shenzhen Qianhai Homerun Technology Co., Ltd. specializes in developing smart pet technology aimed at enhancing the lives of pet owners. Founded in 2015 and headquartered in Guangzhou, China, the company creates innovative products such as smart pet feeders, pet fountains, and smart cat toys. Utilizing artificial intelligence, Homerun Technology focuses on designing solutions that cater to the needs of urban pet owners, particularly those who may have busy lifestyles. The company employs a skilled team of researchers from both domestic and international backgrounds to ensure high-quality development of its products. By integrating smart hardware into daily life, Homerun Technology aims to redefine the pet ownership experience and contribute positively to the pet industry.
Zhongke Tuoda
Series A in 2023
Zhongke Tuoda focuses on addressing fundamental challenges in China's agriculture through innovative physical technology. The company develops fertilizers and pesticides designed to minimize pollution and enhance agricultural environmental protection. By prioritizing the safety of agricultural products, Zhongke Tuoda aims to optimize supply-side structures and reduce the reliance on chemical fertilizers and pesticides that pose risks to both human health and the environment. Their commitment to sustainable agricultural practices reflects an effort to improve the overall safety and quality of agricultural output in China.
Voyager Technology
Series B in 2023
Voyager Technology Inc. is a manufacturer of automotive electronics systems, specializing in advanced driving assistant and autonomous driving solutions. Founded in 2013 and headquartered in Shanghai, China, the company focuses on key areas such as environmental perception, intelligent decision-making, and control execution. Voyager Technology aims to deliver safe and efficient intelligent travel solutions to its customers.
Hainayun
Series A in 2022
Hainayun, a prominent entity within the Haier Group, focuses on developing an Internet of Things (IoT) digital city eco-platform in China. The company is dedicated to creating smart communities and smart parks essential for building smart cities. Hainayun aims to establish itself as a leader in this sector by setting industry standards that promote the development of a Digital China. Its offerings include digital infrastructure construction, building life cycle management, and services related to the Artificial Internet of Things (AIoT) and big data operations. Through these initiatives, Hainayun is positioned to facilitate the establishment of advanced digital urban environments.
EPiCMEMS
Venture Round in 2022
EPiCMEMS, a local chip company based in Xiamen, specializes in the development of RF front-end solutions, focusing on 4G+ and 5G RF filters and chips. The company aims to advance the domestic chip industry by producing high-speed, high-quality 5G chips tailored for mobile devices and the Internet of Things (IoT). With operational facilities in Xiamen and Zhangjiang, along with sales and customer support centers in Shenzhen, Xi'an, and Beijing, EPiCMEMS is committed to enhancing connectivity and stability for users across the mobile and IoT sectors.
GAC Aion New Energy Automobile
Series A in 2022
GAC Aion New Energy Automobile is a Chinese manufacturer of electric vehicles, established in 2017 as a sub-brand of Guangzhou Automobile Corporation and officially launched as a marque in 2020. The company focuses on the development of new energy automobiles, aiming to deliver intelligent vehicles that enhance the driving experience for customers. GAC Aion emphasizes innovation and sustainability in its product offerings, contributing to the growing electric vehicle market in China.
Linli New Energy
Series B in 2022
Linli New Energy is a smart hardware company that develops and manufactures precursors of lithium iron phosphate cathode materials. It was founded in 2016 in Wuhan, Hubei, China.
MicroPort (Shanghai)
Post in 2022
MicroPort (Shanghai) is a prominent developer, manufacturer, and marketer of advanced medical devices in China, primarily focusing on minimally invasive products for treating vascular diseases. Established in May 1998, the company specializes in a range of cardiovascular and diabetes devices, with its flagship product being a second-generation cobalt-chromium alloy drug-eluting stent. Additionally, MicroPort produces various vascular stent-grafts designed for addressing vascular conditions, as well as innovative stents for applications in the brain and other surgical contexts. The company's products have been utilized in over 1,100 hospitals across China and are exported to more than 20 countries in regions such as Asia Pacific (excluding China), South America, and Europe. MicroPort is committed to enhancing healthcare outcomes through its cutting-edge medical technologies.
Origin Quantum
Series B in 2022
Origin Quantum is a full-stack quantum computing company based in China, established in 2017. The company specializes in the development and application of quantum computing technologies, including quantum chips, measurement and control systems, and quantum software. It offers a quantum computing cloud service platform that facilitates access to quantum computing resources beyond laboratory settings. Origin Quantum is committed to advancing the engineering and industrialization of quantum computing in China, aiming to accelerate its applications across various sectors, including quantum artificial intelligence.
TargetRx
Series B in 2022
Shenzhen TargetRx, Inc. is a pharmaceutical research and development company based in Shenzhen, China, established in 2014. As a Sino-American joint venture, it focuses on the creation of innovative anti-tumor drugs, specializing in third-generation small molecule targeted therapies for cancer patients. The company is dedicated to addressing challenges such as acquired drug resistance in cancer treatment. Under the leadership of Dr. Yihan Wang, a prominent medical expert with extensive experience in small molecule targeted therapies, Shenzhen TargetRx aims to position itself as a leading platform for targeted drug development. The company engages in the design, screening, evaluation, optimization, and research of original anti-tumor drug candidates, holding independent intellectual property rights to its innovations. With a commitment to improving cancer treatment outcomes, Shenzhen TargetRx strives to transform cancer from a leading cause of mortality into a manageable chronic condition.
Tuowei Tianhai
Series A in 2022
TWTH committed to minimizing export costs of logistics in China by establishing the most convenient and efficient Sino-US transport brand. It is dedicated to providing Sino-US ocean freight LCL Door-to-Door service, air freight Door-to-Door service, ocean freight FCL Door-to-Door service, international express service, CNRAM and other international freight services.
Shenzhen MTC Company
Post in 2022
Shenzhen MTC Co., Ltd. is a China-based company established in 2005, headquartered in Shenzhen. It specializes in the design, development, and manufacturing of a diverse range of digital products, including LCD TVs, set-top boxes, LED components, and network communication devices. The company also engages in the production of Internet entertainment products and offers advanced television technologies such as 3D, 4K, and QLED TVs. Additionally, Shenzhen MTC provides residential and commercial lighting solutions, encompassing decorative and functional lightings, as well as outdoor lighting products. Through continuous technological innovation, the company strives to enhance its product offerings and improve its systems.
Unitree Robotics
Series B in 2022
Unitree Robotics, founded in 2016 and based in Hangzhou, China, specializes in the development of innovative robotic solutions for consumer and industrial markets. The company's diverse portfolio features a range of robots, including quadrupeds like Laikago, a four-legged robodog designed as a research platform for scientists and roboticists. Additionally, Unitree Robotics offers humanoid robots and advanced perception systems, catering to various applications across different sectors.
Phylion Battery
Venture Round in 2022
Phylion Battery is a manufacturer based in Suzhou, China, specializing in the development, production, and sales of lithium-ion batteries. Utilizing lithium manganate as its positive electrode material, the company has established an annual production capacity of 5GWh. With over 15 years of experience in technology transformation, Phylion has successfully served 8 million end users and provided battery solutions for more than 45,000 electric vehicles globally. The company is recognized as a high-tech enterprise in the power lithium battery sector and is actively involved in research and development within the energy storage field. Phylion is committed to delivering innovative power supply solutions for new energy vehicles and various industrial applications worldwide.
Regend Therapeutics
Series B in 2022
Regend Therapeutics is a leading company in the field of human organ regenerative medicine, specializing in the development of stem cell therapy products. Its flagship product, REGEND001, is the world's first autologous stem cell preparation for treating respiratory diseases and has received approval from the State Food and Drug Administration. Regend Therapeutics is notable for being the first organization in China to be registered for conducting clinical research on stem cells, with its operations overseen by the National Health and Health Commission. The company is recognized as a key player in research and development by the Ministry of Science and Technology. Regend has achieved ISO9001:2008 quality management system certification, and its stem cell preparation complies with various national and international standards, including China Metrology Accreditation and the China Conformity Assessment Committee. All clinical programs are conducted in accordance with regulatory guidelines and are registered with the National Trial Global Database of the National Institutes of Health. The company's research focuses on solutions for interstitial lung disease, assisted reproduction, stem cell storage, and chronic obstructive pulmonary disease.
Hozon
Series D in 2022
Zhejiang Hozon New Energy Automobile Co., Ltd., founded in 2014 and headquartered in Tongxiang, China, specializes in the design and manufacture of electric vehicles. The company produces models such as the Nezha U, Nezha N01, and Eureka 02, focusing on integrating innovative technology through research and development. Hozon emphasizes intelligent manufacturing and multi-channel sales services, aiming to deliver high-quality, cost-effective intelligent electric vehicles. By prioritizing advancements in electricity, intelligence, and connectivity, Hozon seeks to enhance the user experience, providing a simple, intuitive, and comfortable mode of transportation. The company also maintains research and development centers in both China and the United States.
Panchip
Private Equity Round in 2022
PanChip is a designer and developer of short-distance wireless communication and Internet of Things (IoT) chips, established in 2010 and based in Suzhou, China. The company specializes in creating low-power RF chips, including real-time clock chips and touch screen controller chips, tailored for various applications such as wireless mice, audio devices, mobile phone touch screen modules, keyboards, remote controls, toys, game keypads, and industrial control systems. Additionally, PanChip has developed a wireless spread spectrum communication platform, low-power WAN physical layer chips, and high-precision indoor positioning systems, aiming to provide advanced and high-quality domestically produced chip solutions for businesses.
H-CHIP TECH
Venture Round in 2022
H-CHIP TECH is a high-end optoelectronic research and development company based in Tianjin, China. It focuses on the development of micro-nano optoelectronic chips for industrial clients, particularly in the realm of distributed feedback (DFB) semiconductors. The company's expertise lies in creating advanced optoelectronic chips that provide reliable technological support for the optical communication industry, catering to the growing demand for innovative solutions in this field.
Value Simplex
Series B in 2021
Value Simplex is a company based in Shanghai, China, specializing in big data and machine learning services tailored for the financial industry. Founded in 2017, it offers a platform that integrates external data with advanced analytical frameworks to enhance investment research. By focusing on the development of intelligent decision-making tools, Value Simplex provides clients with alternative data and knowledge graphs that support accurate projections regarding company performance and product viability. This approach facilitates long-term data accumulation, enabling customers to uncover new insights from time-series data and improve their investment decision-making efficiency.
Leyue Health
Series B in 2021
Leyue Health, operated by Leyo Information Technology (Shanghai) Co., Ltd., is an innovative platform that integrates internet technology with medical services to streamline the claims process for commercial health insurance. The company has developed an intelligent settlement system that connects medical institutions directly with insurers, allowing for real-time online claims processing. This advancement significantly reduces the traditional claims settlement time, which can take up to 30 days, thereby addressing common challenges such as complicated reimbursement procedures and claims difficulties faced by merchants. In addition to its core services, Leyue Health offers a mobile application for users to manage appointments, make payments, and access test results, alongside providing Wi-Fi services in hospitals. This comprehensive approach aims to enhance the efficiency and accessibility of the healthcare reimbursement process.
Jimuyida
Series B in 2021
Shenzhen Jimuyida Technology Co., Ltd., located in Shenzhen, China, specializes in 3D digital technology, offering a range of products and services that include 3D scanners, engineering modeling services, and home improvement design tools. The company employs advanced technologies such as holography, augmented reality (AR), and virtual reality (VR) to provide customized 3D solutions for various sectors, including retail, design, and real estate. Its software facilitates the creation of detailed, rotatable models, enhancing the visualization and presentation of products for customers. Additionally, Jimuyida has established a research and development center in Wuhan to further innovate in the field of 3D technology.
Harmony Cloud
Series C in 2021
Harmony Cloud, operating as Hangzhou HarmonyCloud Technology Co., Ltd., is a cloud computing startup focused on enhancing IT support for traditional enterprises. The company offers an enterprise Container as a Service (CaaS) platform designed for efficient hybrid cloud management, leveraging the Kubernetes framework. Its platform incorporates advanced technologies such as elastic computing, distributed deployment storage, and software-defined networking, along with robust security features like mirror-level security scanning. Additionally, it provides a user-friendly graphical interface for cloud operations and maintenance, enabling customers to manage resources and applications more effectively. This comprehensive approach aims to accelerate application delivery and improve operational efficiency for businesses in the Chinese market.
EQ Consulting
Seed Round in 2021
EQ Consulting is a financial software solution provider that specializes in consulting services and comprehensive solutions for valuation, risk control, and quantitative analysis. The firm primarily serves large and medium-sized financial institutions, including over ten major banks and financial entities in Hong Kong and Singapore. EQ Consulting's core offerings encompass business consulting, product development, project implementation, and system solutions. Additionally, the company provides customized financial product quantitative modeling, front-end trading, risk control, and back-office solutions. Recent funding has been allocated to enhance product development, research new computing technologies, expand business operations, and build overseas quantitative analysis teams.
Beijing Sudo Technology
Series A in 2021
Beijing Sudo Technology specializes in privacy protection services through comprehensive engineering solutions. The company has developed an encryption platform that enables secure data collaboration by utilizing advanced technologies such as cryptography, federated learning, and robust data engineering. This platform facilitates multi-party data collaboration while ensuring that original data remains untransmitted, allowing clients to work together securely and privately.
Leads Biolabs
Series C in 2021
Leads Biolabs is a biotechnology company focused on developing innovative antibody-based therapeutics to address unmet medical needs in oncology and immunological diseases. Founded in 2014 and headquartered in China, the company has established a strong research and development pipeline featuring over ten projects centered on monoclonal and bispecific antibodies for cancer immunotherapy. By concentrating on tumor immunotherapy, Leads Biolabs aims to enhance treatment outcomes and access for patients globally, thereby improving their medical conditions and overall quality of life.
Zhiduoji Microelectronics
Series C in 2021
Zhiduoji Microelectronics focuses on the research and development of programmable logic circuit device technology. Established in 2012, it is headquartered in Xi'an, and has an EDA software research center in Beijing.
Jiepei.com
Series B in 2021
Jiepei.com Inc. is an online marketplace based in Hangzhou, China, specializing in the manufacturing of printed circuit boards (PCBs) and related electronic components. The company operates Jieji Extreme Speed PCB Super Factory, which aims to create a collaborative platform for the electronic information industry. Jiepei.com focuses on various sectors including consumer electronics, communications equipment, industrial control, instrumentation, intelligent hardware, and the Internet of Things. It offers professional one-stop services such as PCB customization, surface mount technology (SMT), and component distribution, catering to manufacturers in the electronics field.
IPLUSMOBOT
Series B in 2021
IPLUSMOBOT is one of the global leading companies in the autonomous mobile robot field, ranking the first of China industrial logistics natural navigation AMR market occupancy. IPLUSMOBOT was founded in 2016, whose headquarter is in Hangzhou and its subcompany have been established in Shenzhen and Tokyo. It provides logistics automatic, digital and intelligentized products to manufacturing industry, and helps enterprises increase the configuration efficiency of production and circulation resources, and integrated operation efficiency and benefits. So far, IPLUSMOBOT has served over 1000 customers, and the business scenes cover such industries as semiconductor, FPD, electronics, Lithium battery, photovoltaic, automobile, aviation, household electrical appliances, pharmaceutical, energy, food industry and so on.
Yunphant Blockchain
Series B in 2021
Yunphant Blockchain is a China-based company that specializes in designing and developing blockchain platforms. Founded in 2014, it offers a range of services and products aimed at enhancing the financial industry. The company's backend as a service (BaaS) platform supports applications such as equity and bond trading, notary certification, data security, and supply chain finance. Its offerings include a Blockchain service platform and a Blockchain monitor platform, which provide real-time monitoring of node performance, block generation times, and system exceptions. Additionally, Yunphant Blockchain features a hierarchy ledger, segregated business logic, consortium blockchain capabilities, a YBFT consensus algorithm, and various encryption methods. The company's focus on performance, security, privacy, and scalability allows clients to effectively utilize blockchain technology across multiple sectors.
Longcheer
Series B in 2021
Longcheer is a Shanghai-based company that specializes in providing design solutions for mobile telecommunications devices. Founded in 2002, it offers a comprehensive range of services, including hardware and software development, system testing, and exterior design. The company is involved in the research, development, and manufacturing of various terminals, such as smartphones, tablets, AI PCs, XR products, AIoT devices, and automotive electronics. Additionally, Longcheer manufactures, sells, and trades mobile handsets, printed circuits, data products, and related materials. Beyond its core technology services, Longcheer also engages in property investment activities.
TytoCare
Series D in 2021
TytoCare Ltd. is a healthcare technology company based in Netanya, Israel, with an additional office in New York, New York. Founded in 2011, TytoCare develops handheld devices and applications that facilitate on-demand medical examinations and diagnoses through virtual consultations with healthcare providers. Its product offerings include TytoHome for consumers, TytoPro for healthcare professionals, and TytoClinic for remote care locations. These solutions enable users to perform self-examinations of various body systems, including the heart, lungs, skin, and throat, while providing remote access to physicians for evaluation and treatment of common conditions such as ear infections, flu, and respiratory issues. The platform incorporates a cloud-based data repository, analytics, and machine learning algorithms, enhancing the accuracy and user experience of remote healthcare services. TytoCare has established a strategic partnership with Novant Health to further expand its reach in the telehealth market.
Moore Threads
Seed Round in 2021
Moore Threads, founded in 2020 and based in Beijing, China, specializes in developing Graphics Processing Unit (GPU) technology and services. The company focuses on enabling visual computing, artificial intelligence, and high-performance computing applications for a diverse range of sectors, including gaming and the creative industry. By providing advanced GPU technology and services for data centers, edge computing servers, professional workstations, and high-performance PCs, Moore Threads helps clients achieve significant computational power for their processes.
Cryofocus Biotech
Series B in 2021
Cryofocus Biotech is a Shanghai-based cryoablation device manufacturer, focusing on the application of cryogenic technology in the field of cardiovascular interventional therapy.
Sino Vision
Series D in 2020
SinoVision is a medical device manufacturing company based in China, established in 2012. It specializes in the development of computed tomography (CT) scanners, offering a range of products including 16-Slice, 32-Slice, and 64-Slice CT scanners. The company also provides advanced technologies such as the sROBOT robot CT navigation system and sAI intelligent imaging solutions. SinoVision holds intellectual property for CT detectors and designs X-ray tubes and high-voltage power supplies specifically for CT scanners. Additionally, it operates a cloud diagnosis platform that integrates CT image post-processing workstations with an online consultation platform, facilitating comprehensive imaging diagnoses for healthcare professionals and institutions.
Htrip
Series A in 2020
Htrip is a tourism company based in Guangzhou, China, that focuses on data analysis for hotels. Founded in 2016, it enhances hotel services and profitability by tracking user habits. Htrip specializes in developing an Internet communication platform for hotels, which includes upgrading interactive television, Wi-Fi, and Internet of Things (IoT) hardware in guest rooms. The company achieves this through self-investment in technology or partnerships with hotels, integrating its solutions with existing property management systems.
UnionTech
Series A in 2020
UnionTech is a Chinese software company established in 2019, headquartered in Beijing. It specializes in developing and providing basic software solutions, particularly focused on operating systems. The company aims to create a robust innovation ecosystem for Chinese operating systems, offering products that are safe, stable, intelligent, and user-friendly for various industries. UnionTech's primary product is the Unity Operating System, which is compatible with Linux and designed to enhance operational efficiency for users. To support its initiatives, UnionTech has established local technical support institutions, research and development centers, and software and hardware adaptation centers in several major cities, including Wuhan, Shanghai, Guangzhou, and Nanjing.
Eigencomm
Series B in 2020
EigenCOMM Ltd. is a Shanghai-based company established in 2017, specializing in the research, development, and sales of cellular network internet chips. The firm focuses on providing complete solutions for Internet of Things (IoT) ecosystems, particularly in the realm of smart home appliances. EigenCOMM's product line includes standard NB-IoT terminal chips, which ensure comprehensive coverage of cellular data connections and extended standby times, positioning the company as a key player in the IoT market.
FJ Dynamics
Venture Round in 2020
FJ Dynamics, established in 2017, is a global robotic solutions provider headquartered in China. The company specializes in developing intelligent logistics robots tailored for the agricultural industry, integrating technologies such as big data, IoT, deep learning, autonomous driving, and machine vision. Their product suite includes intelligent ground robots, unmanned logistics terminals, agricultural robots, and high-speed rice transplanters, all designed to enhance productivity and efficiency in the agricultural sector.
Chasing Innovation
Series A in 2020
Chasing Innovation Technology, established in 2016 and headquartered in Shenzhen, China, specializes in the development and manufacturing of submersible drones. With additional offices in Beijing, Kunming, and Chengdu, the company was founded by a team of divers and technology enthusiasts with experience from notable firms. Its flagship product, the Gladius, is designed for underwater exploration and is capable of diving up to 100 meters while offering a horizontal range of 500 meters. The drone can operate underwater for up to three hours, capturing high-quality images and videos in Ultra HD, which can be stored internally or live-streamed in real-time. The Gladius serves a variety of applications, including diving, fishing, island exploration, search and rescue operations, and aquaculture monitoring, making it a versatile tool for both recreational and professional use.
LP Pharmaceuticals
Series C in 2020
LP Pharmaceuticals (Xiamen) Co., Ltd., located in Xiamen Biomedical Industry Base which formulates and manufactures pharmaceuticals with enhanced delivery properties. The company was founded in 2012 by a group of scientists and business professionals with extensive experience in the US and Chinese pharmaceutical industry. Proprietary delivery platforms include mucosal and oral controlled release. Therapeutic areas currently concern central nervous system, digestive system, cardiovascular, cancer and AIDS.
Wenge Group
Series C in 2020
Beijing Zhongke Wenge Technology Co., Ltd., located in Beijing, China, specializes in big data applications for the media sector. The company focuses on providing technological solutions to facilitate the transformation and enhancement of media communication in China. It is actively engaged in the research and development of new media big data technologies and systems, addressing the needs of media, government, and enterprises. Zhongke Wenge has developed a comprehensive suite of products, including the "Wenhai" new media big data platform, the "Wen Ge" central kitchen, and the "Wen Si" decision-making service. Additionally, it offers key services such as the “cloud trace” communication monitoring system, the “Yunyong” media visualization analysis system, and the “Yayi” text semantic analysis component, which collectively support media organizations in improving communication effectiveness and decision-making capabilities.
Shanghai Horizon Medical Technology
Venture Round in 2020
Shanghai Horizon Medical Technology focuses on medical solutions its business covers the R&D, manufacturing, marketing, and technical support of products at every step of the ART treatment process, including egg and sperm collection, fertilization, embryo culture, cryopreservation, and embryo transfer. It was founded in 2018 and headquartered in Shanghai, China.
TargetRx
Series A in 2020
Shenzhen TargetRx, Inc. is a pharmaceutical research and development company based in Shenzhen, China, established in 2014. As a Sino-American joint venture, it focuses on the creation of innovative anti-tumor drugs, specializing in third-generation small molecule targeted therapies for cancer patients. The company is dedicated to addressing challenges such as acquired drug resistance in cancer treatment. Under the leadership of Dr. Yihan Wang, a prominent medical expert with extensive experience in small molecule targeted therapies, Shenzhen TargetRx aims to position itself as a leading platform for targeted drug development. The company engages in the design, screening, evaluation, optimization, and research of original anti-tumor drug candidates, holding independent intellectual property rights to its innovations. With a commitment to improving cancer treatment outcomes, Shenzhen TargetRx strives to transform cancer from a leading cause of mortality into a manageable chronic condition.
QureBio
Series A in 2020
QureBio focuses on the research and development of innovative macromolecular biopharmaceuticals. Its goal is to develop new therapeutic drugs for the treatment of refractory cancer, autoimmune diseases, and metabolic diseases in China and the world to benefit patients. QureBio has multiple technology platforms for antibody drug development including phage display technology platforms and hybridoma antibodies technology platform and monoclonal antibody platform. The company was founded in 2017 and is based in Pudong District, Shanghai.
Encootech
Series B in 2020
Encootech, Co., Ltd., established in July 2017 and headquartered in Shanghai, China, specializes in the development of intelligent robotic process automation (RPA) platforms and solutions. The company, recognized as the first high-tech firm in China to focus on RPA technology, operates a research and development center in Suzhou and has expanded its presence by opening a subsidiary in Tokyo to cater to the Japanese market. Encootech is known for its flagship product, Digi4th, an intelligent RPA robot platform developed by a core team of experts previously affiliated with Microsoft's cloud computing department. The company's offerings are designed to enhance operational efficiency across various sectors, including the internet, finance, energy, telecommunications, and manufacturing, facilitating digital transformation and improving traditional industry practices.
GenFleet Therapeutics
Series B in 2020
GenFleet Therapeutics, established in 2017 and headquartered in Shanghai, China, is a biotechnology company focused on cancer research and development. It specializes in creating therapeutic molecules, including signal transduction regulators, tumor microenvironment modulators, and transcription factors, to target various cancer systems. The company aims to develop innovative molecular-level pharmaceuticals and antibody drugs that can effectively stimulate the body's immune response against tumors. GenFleet serves both domestic and international clients.
Lachesis
Series B in 2020
Lachesis is a high-tech company based in Shenzhen, China, specializing in clinical applications that integrate information and communications technology with internet technology. The company develops intelligent products and services aimed at enhancing the efficiency of healthcare delivery for doctors, nurses, patients, and hospitals. Its offerings include a bedside nursing solution, an interactive smart ward solution, and an IoT platform, all designed to improve management efficiency and accuracy in medical assessments. By providing mobile medical intelligent hardware and application software, Lachesis aims to advance mobile nursing and intelligent medical practices within healthcare institutions.
Maijing Gene
Series B in 2020
Maijing Gene is a gene detection technology company that specializes in R&D, production, and sales of molecular diagnostic products. It is also committed to promoting the application of second-generation high-throughput sequencing technology in the field of precision medicine. Maijing Gene was established in 2015 and is based in Guangzhou, China.
RemeGen
Private Equity Round in 2019
RemeGen, Ltd. is a biopharmaceutical company based in Yantai, Shandong Province, China, focused on addressing unmet medical needs for patients with life-threatening conditions. The company specializes in the research, development, manufacturing, and commercialization of innovative biologics, particularly monoclonal antibodies and antibody-drug conjugates. RemeGen's leading products include Telitacicept, aimed at treating systemic lupus erythematosus, and Disitamab Vedotin, designed for various cancers. The company’s therapeutic offerings target significant health issues, including autoimmune diseases, oncology, and ophthalmology. With operations in both China and the United States, RemeGen primarily generates its revenue from the Chinese market.
Eigencomm
Venture Round in 2019
EigenCOMM Ltd. is a Shanghai-based company established in 2017, specializing in the research, development, and sales of cellular network internet chips. The firm focuses on providing complete solutions for Internet of Things (IoT) ecosystems, particularly in the realm of smart home appliances. EigenCOMM's product line includes standard NB-IoT terminal chips, which ensure comprehensive coverage of cellular data connections and extended standby times, positioning the company as a key player in the IoT market.
Htrip
Series A in 2019
Htrip is a tourism company based in Guangzhou, China, that focuses on data analysis for hotels. Founded in 2016, it enhances hotel services and profitability by tracking user habits. Htrip specializes in developing an Internet communication platform for hotels, which includes upgrading interactive television, Wi-Fi, and Internet of Things (IoT) hardware in guest rooms. The company achieves this through self-investment in technology or partnerships with hotels, integrating its solutions with existing property management systems.
Akeso Biopharma
Series D in 2019
Akeso Biopharma, based in Zhongshan, China, operates as a contract research organization (CRO) specializing in the discovery and development of antibody and protein drugs. Founded in 2012, the company provides comprehensive CRO services to both domestic and international pharmaceutical clients, focusing on areas such as protein expression, antibody generation, assay development, and humanization. Akeso has developed an extensive biopharmaceutical research and development platform, with a robust product pipeline that includes over 30 drugs targeting cancers, autoimmune diseases, inflammation, and cardiovascular conditions. Among these, 17 drugs have progressed to clinical stages, including two first-in-class bi-specific antibody drugs. The company collaborates with various pharmaceutical firms to innovate and develop new drug candidates, establishing itself as a leader in the industry through its advanced facilities and expertise.
Golden Technology
Series B in 2019
Golden Technology is a big data service company based in China that specializes in providing electronic invoicing solutions through blockchain technology. The company has developed a digital invoicing and transaction record-keeping platform designed to serve various sectors, including grocery retailers, parking lots, and restaurants. Its platform offers a range of services such as electronic invoicing, reimbursement, record-keeping, and transaction inspection and management. By leveraging blockchain, Golden Technology aims to provide convenient and cost-effective alternatives to traditional paper-based receipts, enhancing the efficiency and transparency of financial transactions.
Fapiaoer
Series B in 2019
Fapiaoer is a Chinese electronic invoicing service provider under Tencent-backed Chinese project incubator and group-buying platform GaoPeng. Based on a variety of business success stories, with a strong operating, technical, product team, Gao Peng internal restructuring team to provide electronic invoicing services in an effort to create the most convenient and most reasonable electronic invoice preparation, preservation, and reimbursement experience for users. , Tencent and U.S. GROUPON Each group invested 50 million U.S. dollars to develop a group purchasing business company to become: Wechat commercialization project incubation platform, Tencent eco-layout early investment platform, Group purchasing model integration optimization of new e-commerce platform and other three business lines go hand in hand with diversified technology The company, currently Tencent, is the single largest shareholder of Gao Peng.
Hrain Biotechnology
Series B in 2019
Hrain Biotechnology is a developer of tumor immunotherapy technologies focused on providing targeted treatments for cancer patients. The company specializes in Chimeric Antigen Receptor T-cell (CAR-T) therapy, which leverages biological and cellular technology to deliver precise care. Hrain Biotechnology has established clinical trial platforms and centers in multiple locations, including Beijing, Jiangsu, Chongqing, and Henan, facilitating research and development in innovative cancer treatments. By enabling clinics and hospitals to utilize advanced medical solutions, Hrain Biotechnology aims to enhance patient care and improve treatment outcomes in oncology.
Mino Space
Series A in 2019
Mino Space is a private commercial satellite company focused on the development and application of micro-nano satellite systems. Established in 2017 and based in Beijing, the company specializes in research and development, manufacturing services, and the integration of satellite technologies. Mino Space independently designs and develops micro-nano satellite platforms and core components, including electronic communication and optical payloads. The company has significant experience in satellite communication system integration and also develops terrestrial communication terminals. Mino Space offers integrated information system solutions that leverage satellite resources for various sectors, including defense and industry. Its capabilities encompass the coordination of satellite development and overall project management, contributing to advancements in space exploration and communication technologies.
ArchForce Technology
Series B in 2019
ArchForce Technology, established in 2016, is a Shenzhen-based company that specializes in designing, developing, and providing core business systems and platforms for the securities and financial industry. Its product suite includes a message interconnection platform, trading platform, risk control system, and a trading highway, catering to the needs of various financial institutions such as securities firms, funds, banks, and insurance companies. The company's offerings span transactions, time clearing, risk management, speed markets, investment management, and wealth management marketing services, aiming to enhance the efficiency and capabilities of China's financial infrastructure.
Anlogic
Series D in 2019
Shanghai Anlogic Infotech Co., Ltd., founded in 2011 and located in Zhangjiang Hi-Tech Park, Pudong New Area, focuses on the research, development, design, and sales of programmable logic devices. The company specializes in providing cost-effective field programmable gate arrays (FPGAs), programmable system-on-chips, custom embedded eFPGA intellectual property, and related software design tools. Anlogic aims to deliver innovative system solutions tailored to meet the diverse needs of its customers in various industries.
Innoviz Technologies
Series C in 2019
Innoviz Technologies Ltd. specializes in designing and manufacturing solid-state LiDAR sensors and perception software that facilitate the mass production of autonomous vehicles. The company offers InnovizPro, a solid-state LiDAR known for its exceptional performance and value, and InnovizOne, an automotive-grade LiDAR sensor that delivers advanced 3D sensing capabilities for various levels of autonomous driving (Levels 3 to 5). Innoviz's products also include solutions for object identification and tracking, sensor fusion, as well as mapping and localization. The company partners with a range of notable investors and strategic allies, enhancing its position in the industry. Founded in 2016 and headquartered in Rosh HaAyin, Israel, Innoviz Technologies aims to provide comprehensive solutions for original equipment manufacturers (OEMs) and Tier-1 suppliers involved in the development of autonomous vehicles, serving markets that include passenger cars, robotaxis, shuttles, delivery vehicles, and logistics.
Innoviz Technologies
Series C in 2019
Innoviz Technologies Ltd. specializes in designing and manufacturing solid-state LiDAR sensors and perception software that facilitate the mass production of autonomous vehicles. The company offers InnovizPro, a solid-state LiDAR known for its exceptional performance and value, and InnovizOne, an automotive-grade LiDAR sensor that delivers advanced 3D sensing capabilities for various levels of autonomous driving (Levels 3 to 5). Innoviz's products also include solutions for object identification and tracking, sensor fusion, as well as mapping and localization. The company partners with a range of notable investors and strategic allies, enhancing its position in the industry. Founded in 2016 and headquartered in Rosh HaAyin, Israel, Innoviz Technologies aims to provide comprehensive solutions for original equipment manufacturers (OEMs) and Tier-1 suppliers involved in the development of autonomous vehicles, serving markets that include passenger cars, robotaxis, shuttles, delivery vehicles, and logistics.
KK Group
Series C in 2019
KK Group operates an online-to-offline marketplace in China that focuses on imported products. The company sources a diverse range of items, including snacks, personal care products, makeup, home furnishings, and stationery, from renowned international brands. Through its platform, KK Group allows consumers to purchase these products from physical stores around the world using their mobile devices, bridging the gap between online shopping and offline retail. This approach provides users with direct access to premium imported consumer goods, enhancing their shopping experience.
MabPlex
Series A in 2019
MabPlex International Ltd is a contract development and manufacturing organization specializing in biopharmaceuticals, including monoclonal antibodies, recombinant proteins, antibody-drug conjugates, and bispecifics. Founded in 2013, the company operates from its headquarters in Yantai, China, and has an additional office in Fremont, California. MabPlex provides a comprehensive range of services that encompass all stages of drug development, from DNA to finished drug products. Its offerings include customized mammalian cell medium, cell banking, and the manufacturing of monoclonal antibody active pharmaceutical ingredients, as well as fill and finish services for biologics and antibody-drug conjugates. The company aims to deliver high-quality solutions for bio-manufacturing to its global partners.
TytoCare
Series C in 2019
TytoCare Ltd. is a healthcare technology company based in Netanya, Israel, with an additional office in New York, New York. Founded in 2011, TytoCare develops handheld devices and applications that facilitate on-demand medical examinations and diagnoses through virtual consultations with healthcare providers. Its product offerings include TytoHome for consumers, TytoPro for healthcare professionals, and TytoClinic for remote care locations. These solutions enable users to perform self-examinations of various body systems, including the heart, lungs, skin, and throat, while providing remote access to physicians for evaluation and treatment of common conditions such as ear infections, flu, and respiratory issues. The platform incorporates a cloud-based data repository, analytics, and machine learning algorithms, enhancing the accuracy and user experience of remote healthcare services. TytoCare has established a strategic partnership with Novant Health to further expand its reach in the telehealth market.
Vhall
Series D in 2018
Vhall is an online activity marketing and commercial platform based in China that specializes in virtual meetings and live broadcasting services. Affiliated with Beijing Vhall Time Science and Technology Co., Ltd., Vhall aims to deliver a world-class online marketing experience for Chinese enterprises. The platform provides an interactive environment where users can engage in 3D virtual reality meetings, participate in live seminars, and view product demonstrations. Vhall's services facilitate remote communication for enterprises, enhancing work efficiency and saving time by enabling seamless interactions without the need for in-person meetings.
Databaker Technology
Series A in 2018
Databaker, Inc. is an AI company based in Beijing, China, founded in 2016, that specializes in intelligent voice interaction and comprehensive data services. The company offers a range of solutions, including voice synthesis, voice recognition, and image data annotation, as well as text-to-speech services. By leveraging its open AI+SaaS platform, Databaker provides clients with advanced technical capabilities in voice interaction and various forms of data acquisition, such as natural language processing. This enables enterprises to select appropriate voice interaction products tailored to their specific applications, effectively enhancing their operational efficiency and user engagement.
Yunphant Blockchain
Series A in 2018
Yunphant Blockchain is a China-based company that specializes in designing and developing blockchain platforms. Founded in 2014, it offers a range of services and products aimed at enhancing the financial industry. The company's backend as a service (BaaS) platform supports applications such as equity and bond trading, notary certification, data security, and supply chain finance. Its offerings include a Blockchain service platform and a Blockchain monitor platform, which provide real-time monitoring of node performance, block generation times, and system exceptions. Additionally, Yunphant Blockchain features a hierarchy ledger, segregated business logic, consortium blockchain capabilities, a YBFT consensus algorithm, and various encryption methods. The company's focus on performance, security, privacy, and scalability allows clients to effectively utilize blockchain technology across multiple sectors.
Akeso Biopharma
Series C in 2018
Akeso Biopharma, based in Zhongshan, China, operates as a contract research organization (CRO) specializing in the discovery and development of antibody and protein drugs. Founded in 2012, the company provides comprehensive CRO services to both domestic and international pharmaceutical clients, focusing on areas such as protein expression, antibody generation, assay development, and humanization. Akeso has developed an extensive biopharmaceutical research and development platform, with a robust product pipeline that includes over 30 drugs targeting cancers, autoimmune diseases, inflammation, and cardiovascular conditions. Among these, 17 drugs have progressed to clinical stages, including two first-in-class bi-specific antibody drugs. The company collaborates with various pharmaceutical firms to innovate and develop new drug candidates, establishing itself as a leader in the industry through its advanced facilities and expertise.
XTX Technology
Series B in 2018
XTX Technology Limited is a semiconductor company based in Shenzhen, China, specializing in high-reliability and cost-effective memory products. The company manufactures a variety of flash memory solutions, including NAND MCP, NOR MCP, SD NAND, SPI NAND, SPI NOR Flash, and eMMC, which are designed for embedded applications across multiple sectors such as mobile devices, automotive equipment, security systems, point-of-sale terminals, home appliances, and Internet of Things devices. In addition to its memory products, XTX Technology offers SIP assembly services aimed at optimizing customer bill of materials costs and enhancing production efficiency, while also improving software intellectual property security. The company’s innovative technology supports a wide range of applications, contributing to advancements in consumer electronics, network communications, and industrial and medical fields.
Teligene
Series C in 2018
Teligene Ltd. is a pharmaceutical research and development company based in Jiangsu, China, established in 2011. The company specializes in the development of small-molecule drugs, particularly innovative treatments for oncology. Teligene's focus is on the research, development, and industrialization of small molecule targeted anti-tumor drugs, utilizing advanced drug development technologies. The experienced management team is well-versed in contemporary trends and practices in drug development both domestically and internationally. Teligene aims to create original anti-tumor drugs with independent intellectual property rights, addressing emerging areas of research and development in the pharmaceutical field.
Shenzhen Raybow Optoelectronics
Series A in 2018
Shenzhen Raybow Optoelectronics Co., Ltd., established in Shenzhen, China, specializes in the design and manufacture of high-power semiconductor laser chips. Founded by Tsinghua University's Research Institute and industry experts, the company operates a fully functional semiconductor laser chip fabrication line and a packaging and testing facility. Raybow offers some of the market's most powerful and reliable laser diodes, along with advanced testing equipment and services, including design consulting, characterization, and failure mode analysis.
TargetRx
Seed Round in 2018
Shenzhen TargetRx, Inc. is a pharmaceutical research and development company based in Shenzhen, China, established in 2014. As a Sino-American joint venture, it focuses on the creation of innovative anti-tumor drugs, specializing in third-generation small molecule targeted therapies for cancer patients. The company is dedicated to addressing challenges such as acquired drug resistance in cancer treatment. Under the leadership of Dr. Yihan Wang, a prominent medical expert with extensive experience in small molecule targeted therapies, Shenzhen TargetRx aims to position itself as a leading platform for targeted drug development. The company engages in the design, screening, evaluation, optimization, and research of original anti-tumor drug candidates, holding independent intellectual property rights to its innovations. With a commitment to improving cancer treatment outcomes, Shenzhen TargetRx strives to transform cancer from a leading cause of mortality into a manageable chronic condition.
HaploX
Series B in 2018
HaploX Biotechnology Co., LTD., founded in 2014 and based in Shenzhen, China, focuses on developing genomic solutions for personalized medicine, particularly in cancer patient management. The company integrates advanced technologies such as liquid biopsy, gene sequencing, artificial intelligence, and big data to enhance cancer diagnostics. HaploX specializes in extracting and amplifying ultra-low concentrations of DNA from liquid samples, enabling precise detection of circulating tumor DNA. Its innovative tools facilitate tagged sequencing and streamline data management and analysis, aiming to improve the accuracy and effectiveness of cancer detection and treatment strategies.
Chasing Innovation
Seed Round in 2018
Chasing Innovation Technology, established in 2016 and headquartered in Shenzhen, China, specializes in the development and manufacturing of submersible drones. With additional offices in Beijing, Kunming, and Chengdu, the company was founded by a team of divers and technology enthusiasts with experience from notable firms. Its flagship product, the Gladius, is designed for underwater exploration and is capable of diving up to 100 meters while offering a horizontal range of 500 meters. The drone can operate underwater for up to three hours, capturing high-quality images and videos in Ultra HD, which can be stored internally or live-streamed in real-time. The Gladius serves a variety of applications, including diving, fishing, island exploration, search and rescue operations, and aquaculture monitoring, making it a versatile tool for both recreational and professional use.
ArchForce Technology
Venture Round in 2018
ArchForce Technology, established in 2016, is a Shenzhen-based company that specializes in designing, developing, and providing core business systems and platforms for the securities and financial industry. Its product suite includes a message interconnection platform, trading platform, risk control system, and a trading highway, catering to the needs of various financial institutions such as securities firms, funds, banks, and insurance companies. The company's offerings span transactions, time clearing, risk management, speed markets, investment management, and wealth management marketing services, aiming to enhance the efficiency and capabilities of China's financial infrastructure.
Uoko.com
Series C in 2018
Uoko.com, operated by Sichuan UOKO Investment Management Co. Ltd., is an online property leasing platform based in Chengdu, China, founded in 2012. The platform specializes in apartment rental services, targeting young students and professionals in second-tier cities like Chengdu and Wuhan. Uoko.com offers standardized long-term rental apartments while also providing comprehensive property management solutions for homeowners. These services include post-rental offerings such as cleaning, maintenance, and renovation, enabling homeowners to effectively monetize their vacant properties. By focusing on high-quality rental options and community-oriented after-sales services, Uoko.com aims to meet the needs of urban rental groups and enhance the overall rental experience.
Maijing Gene
Series A in 2018
Maijing Gene is a gene detection technology company that specializes in R&D, production, and sales of molecular diagnostic products. It is also committed to promoting the application of second-generation high-throughput sequencing technology in the field of precision medicine. Maijing Gene was established in 2015 and is based in Guangzhou, China.
XTX Technology
Series A in 2018
XTX Technology Limited is a semiconductor company based in Shenzhen, China, specializing in high-reliability and cost-effective memory products. The company manufactures a variety of flash memory solutions, including NAND MCP, NOR MCP, SD NAND, SPI NAND, SPI NOR Flash, and eMMC, which are designed for embedded applications across multiple sectors such as mobile devices, automotive equipment, security systems, point-of-sale terminals, home appliances, and Internet of Things devices. In addition to its memory products, XTX Technology offers SIP assembly services aimed at optimizing customer bill of materials costs and enhancing production efficiency, while also improving software intellectual property security. The company’s innovative technology supports a wide range of applications, contributing to advancements in consumer electronics, network communications, and industrial and medical fields.
Zelgen
Series B in 2018
Zelgen is a biopharmaceutical company based in Suzhou, China, dedicated to the research, development, manufacturing, and sales of innovative medications. The company focuses on creating new chemical and biological drugs for a range of therapeutic areas, including cancer, hematologic diseases, and hepatobiliary conditions. Zelgen aims to address unmet medical needs within the domestic market by providing high-quality, safe, effective, and affordable treatment options. Through its commitment to innovation and R&D, Zelgen aspires to establish itself as a leading player in the Chinese biopharmaceutical sector.
Huada Empyrean Software
Corporate Round in 2018
Beijing Huada Empyrean Software Co., Ltd. is a leading provider of electronic design automation (EDA) software and services in China, operating as a subsidiary of China Electronics Corporation. Established in June 2009 and headquartered in Wang Jing Hi-Tech Park, Beijing, the company specializes in a wide range of solutions, including analog and mixed analog-digital integrated circuit design, digital system-on-chip design optimization, and flat panel design optimization. With nearly three decades of technological advancement and a robust research and development team, Huada Empyrean Software has positioned itself as the largest EDA software supplier in the country. The company also serves as the relying institution of the National IC CAD Engineering Research Center, fostering collaboration with both domestic and international clients. It has established EDA laboratories at various universities to enhance its cooperative efforts in the industry. The company emphasizes professionalism, dedication, collaboration, and innovation as its core values, aiming for mutual development and success with its partners and customers.
Akeso Biopharma
Series B in 2017
Akeso Biopharma, based in Zhongshan, China, operates as a contract research organization (CRO) specializing in the discovery and development of antibody and protein drugs. Founded in 2012, the company provides comprehensive CRO services to both domestic and international pharmaceutical clients, focusing on areas such as protein expression, antibody generation, assay development, and humanization. Akeso has developed an extensive biopharmaceutical research and development platform, with a robust product pipeline that includes over 30 drugs targeting cancers, autoimmune diseases, inflammation, and cardiovascular conditions. Among these, 17 drugs have progressed to clinical stages, including two first-in-class bi-specific antibody drugs. The company collaborates with various pharmaceutical firms to innovate and develop new drug candidates, establishing itself as a leader in the industry through its advanced facilities and expertise.
AZLOOK
Angel Round in 2017
Azlook is a consumer service platform that specializes in high-end fashion, catering primarily to female customers. The company operates both online and offline, offering an experiential shopping experience that connects fashion-conscious consumers in China with premium fashion accessories brands from Europe and Western countries. In addition to showcasing these international brands, Azlook provides tailored clothing services, ensuring that customers receive personalized fashion solutions that meet their specific preferences. By combining a curated selection of luxury fashion items with bespoke tailoring options, Azlook aims to enhance the shopping experience for its clientele.
Dobot
Series A in 2017
Dobot is a prominent provider of robotic arm solutions based in China, focusing on making technology accessible and enjoyable. The company specializes in the development of smart desktop robotic arms that enhance manufacturing process efficiency. These robotic arms can be controlled through mobile devices, voice commands, and gestures, offering versatile and responsive solutions tailored for various industries. By integrating full-sensing capabilities, Dobot's products enable users to improve product quality and work efficiency. From its inception with the first desktop robotic arm to the development of STEAM robot kits, Dobot continuously innovates to expand the possibilities of robotic technology.
Youon Bike
Series A in 2017
Youon Technology Co., Ltd. specializes in providing green transportation services through its Internet of Things technology and data platform. The company operates a comprehensive green sharing travel service platform called Wing of the Line, which is available in 220 cities and encompasses 32,000 shared bicycle stations with a fleet of 800,000 bicycles. Youon aims to promote environmentally friendly travel habits and has implemented public bicycle projects across more than 200 counties in China, contributing to the construction of 30,000 public bicycle sites. The Youon national public bicycle system boasts over 15 million active users, with peak rental activity reaching 2.2 million transactions per day. To enhance service delivery, Youon has established 105 branches and operations centers nationwide, employing approximately 4,500 personnel. The company emphasizes technological and service innovation, offering a platform that supports various methods for bike rental, including QR code scanning through popular payment applications.
Makeblock
Series B in 2017
Makeblock is a company founded in 2013 and headquartered in Shenzhen, China, that offers a do-it-yourself (DIY) robotics construction and programming learning platform. This platform provides mechanical components, various electronic modules, and graphical programming software, allowing STEM and STEAM learners, educators, and hobbyists to design and build modular, programmable robots. Users can create diverse robotic applications, including hovercrafts and cars, fostering hands-on learning and creativity in robotics and programming.
Frontier Biotechnologies
Series C in 2017
Frontier Biotechnologies Inc. is a commercial-stage biopharmaceutical company based in Nanjing, China, established in 2013. The company specializes in discovering, developing, manufacturing, and commercializing innovative medicines aimed at improving patient health, particularly in the areas of anti-HIV treatment and pain management. Its notable products include Aikening, a long-acting HIV fusion inhibitor, and AB001, a transdermal patch for managing musculoskeletal joint pain. Additionally, Frontier Biotech is developing a combination regimen of Albuvirtide and a monoclonal antibody to combat HIV-1. The company's first product received accelerated approval from the National Medical Product Administration in May 2018, marking a significant milestone in its commercial journey. Currently, two other drug candidates are in Phase I and II clinical trials in both China and the United States. Frontier Biotechnologies combines expertise from various fields, including research and development, management, and marketing, to establish itself as a competitive player in the global market for long-acting HIV treatments and immunotherapy.
ASR Microelectronics
Series A in 2017
ASR Microelectronics (Shanghai) Co., Ltd. is a semiconductor manufacturer specializing in chips for mobile intelligent communication terminals, navigation, and various consumer electronics. Founded in April 2015 and headquartered in Shanghai's Zhangjiang Hi-Tech Park, the company develops products including smartphones, modems, and integrated system on chips (SoCs). ASR's research and development efforts are supported by teams based in the United States and South Korea, focusing on technological innovation across mobile communications, the Internet of Things, and smart handheld devices. The company boasts comprehensive capabilities in baseband platform development, particularly following its acquisition of Marvell's Mobile Business Unit in 2017, positioning itself as a key player in China's semiconductor landscape. ASR is dedicated to providing efficient technical support and product solutions across multiple communication standards, including 2G, 3G, and 4G technologies.
Wangyudashi
Series A in 2016
Wangyudashi, which operates wangyuhudong.com, is a specialized platform for internet cafe payment and eSports registry developed by Zhejiang Wangjing Network Technology Co., Ltd. The company claims that the platform has already covered 30,000 Internet cafes in China with over ten million users and daily events of over 30.
DataEye
Series B in 2016
DataEye is a data solutions provider based in Shenzhen, China, specializing in the mobile gaming industry. Founded in 2013, the company offers a digital content marketing platform that includes a range of services such as marketing SaaS tools, strategy research consulting, and creative advertising planning. DataEye supports clients in the gaming and e-commerce sectors by delivering insights into consumer preferences through advanced data retrieval technologies. Its platform enables clients to track data from game operations and player actions, helping them to make informed decisions regarding product development, market strategies, customer support, and brand promotion. By leveraging its expertise, DataEye aims to enhance clients' sales growth and overall marketing effectiveness.
Youmi
Post in 2016
Youmi Media, established in 2010 and headquartered in Guangzhou, China, operates as an intelligent mobile advertising platform. It specializes in connecting advertisers and publishers, offering services such as performance-based advertising, app store optimization, and social media marketing. The company's notable products include ASOGrow, an automatic Google Play ASO platform, JadiDuit, Google's first offer wall, and in-house content media. Youmi aims to help advertisers engage users intelligently and assist its partners, including app developers, media buyers, affiliates, and ad networks, in maximizing revenue.
Zelgen
Series A in 2016
Zelgen is a biopharmaceutical company based in Suzhou, China, dedicated to the research, development, manufacturing, and sales of innovative medications. The company focuses on creating new chemical and biological drugs for a range of therapeutic areas, including cancer, hematologic diseases, and hepatobiliary conditions. Zelgen aims to address unmet medical needs within the domestic market by providing high-quality, safe, effective, and affordable treatment options. Through its commitment to innovation and R&D, Zelgen aspires to establish itself as a leading player in the Chinese biopharmaceutical sector.
Transwarp
Series B in 2016
Transwarp is a technology company based in Shanghai that specializes in big data software solutions for enterprises. It offers a cloud-based platform that serves as an integrated system for data processing and cloud operations. This platform facilitates the management and analysis of data, allowing businesses to effectively store and govern their data throughout its entire life cycle. Additionally, Transwarp provides services related to data integration, modeling, analysis, mining, and circulation, enabling organizations to harness the full potential of their data infrastructure.
Guanmai Technology
Series B in 2016
Guanmai Technology is currently the leading SaaS company in the B2B field of fresh food in China. Guanmai, formerly a fresh delivery company for small farmers and girls , has served nearly 30,000 restaurant companies in Guangdong. In 2014-16, it has deeply practiced the B2B business of food distribution, and has accumulated rich experience and industry knowledge of B2B food distribution.
Afanti
Series B in 2015
Afanti is an IT company engaged in the production and development of network and gaming products. It also offers a study mobile application that provides real-time answers and assistance to primary and middle school students. Afanti was founded in 2000 and is based in Beijing, China.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.